Back

Argatroban anticoagulation for heparin induced thrombocytopenia after Heartmate 3 implantation: a single center experience

18 May 2025 (14:00 - 14:45)
Organised by: Logo
Congress Presentation Part of: LVADs - from rehabilitation to palliative care Ventricular Assist Devices HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Mr Carlos Palacios-Castello

UNIVERSITY HOSPITAL VIRGEN DEL ROCIO, Seville (Spain)

5 More presentations in this session

Presentation thumbnail
Effects of supervised exercise training in patients with left ventricular assist device: an individual participant data meta-analysis
Assistant Professor T. Kambic (Ljubljana, SI)
Abstract Slides Video
Presentation thumbnail
Clinical impact of complete revascularization before left ventricular assist device implantation in patients with severe ischemic cardiomyopathy
Doctor D. Hong (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Design, production and performance testing of a novel axial - flow, axial - flux left ventricular assist device (LVAD) with feedback - controlled physiologic flow and two - way wireless communication
Mr M. Yigit (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Nutritional screening and access in patients with terminal stadium of heart failure preparing for LVAD-BVAD surgery
Doctor T. Anguseva (Skopje, MK)
Abstract Slides Video
Presentation thumbnail
Exploring palliative care needs in HeartMate 3 patients: a cross-sectional study using the IPOS
Doctor I. Santos (Ponta Delgada, PT)
Abstract Slides Video

Access the full session

Session thumbnail
LVADs - from rehabilitation to palliative care

The Event

Event poster

Heart Failure 2025

18 May 2025 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of delayed heparin bridging on bleeding and stroke after heartmate 3 left ventricular assist device implantation
thumbnail
Congress Presentation
Dual or single anticoagulation/antiplatelet therapy in LVAD patients?
thumbnail
Congress Presentation
Efficacy and safety of antithrombotic regimens in patients with durable left ventricular assist devices: a systematic review and bayesian network meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources